Akute und chronisch entzündliche Neuropathien - Therapie[1]

Literatur

• 1 The French Cooperative Group on Plasma Exchange in Guillain-Barre Syndrome . Appropriate number of plasma exchanges in Guillain-Barre syndrome.  Ann Neurol. 1997;  41 298-306
• 2 Bernsen R A, de Jager A E, Schmitz P I, van der Meche F G. Long-term impact on work and private life after Guillain-Barre syndrome.  J Neurol Sci. 2002;  201 13-17
• 3 Comi G, Roveri L, Swan A. et al . A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy.  J Neurol. 2002;  249 1370-1377
• 4 Diener H C, Haupt W F, Kloss T M. et al . A preliminary, randomized, multicenter study comparing intravenous immunoglobulin, plasma exchange and immune adsorption in Guillain-Barre syndrome.  Eur Neurol. 2001;  46 107-109
• 5 Guillain-Barre Syndrome Steroid Trial Group . Double-blind trial of intravenous methylprednisolone in Guillain-Barre syndrome.  Lancet. 1993;  341 586-590
• 6 Dyck P J, O’Brien P, Swanson C, Low P, Daube J. Combined azathioprine and prednisone in chronic inflammatory-demyelinating polyneuropathy.  Neurology. 1985;  35 1173-1176
• 7 Feasby T E, Hartung H P. Drain the roots: a new treatment for Guillain-Barre syndrome?.  Neurology. 2001;  57 753-754
• 8 Federico P, Zochodne D W, Hahn A F, Brown W F, Feasby T E. Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study.  Neurology. 2000;  55 1256-1262
• 9 Fletcher D D, Lawn N D, Wolter T D, Wijdicks E F. Long-term outcome in patients with Guillain-Barre syndrome requiring mechanical ventilation.  Neurology. 2000;  54 2311-2315
• 10 Gorson K C, Allam G, Ropper A H. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy.  Neurology. 1997;  48 321-328
• 11 Hahn A F, Bolton C F, Pillay N. et al . Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study.  Brain. 1996;  119 1055-1066
• 12 Hahn A F, Bolton C F, Zochodne D, Feasby T E. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study.  Brain. 1996;  119 1067-1077
• 13 Hughes R, Bensa S, Willison H. et al . Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy.  Ann Neurol. 2001;  50 195-201
• 14 Mendell J R, Barohn R J, Freimer M L. et al . Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy.  Neurology. 2001;  56 445-449
• 15 Pandey C K, Bose N, Garg G. et al . Gabapentin for the treatment of pain in Guillain-Barre syndrome: a double-blind, placebo-controlled, cross-over study.  Anesth Analg. 2002;  95 1719-1723
• 16 Pritchard J, Mukherjee R, Hughes R A. Risk of relapse of Guillain-Barre syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunisation.  J Neurol Neurosurg Psychiatry. 2002;  73 348-349
• 17 Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group . Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome.  Lancet. 1997;  349 225-230
• 18 Raphael J C, Chevret S, Hughes R A, Annane D. Plasma exchange for Guillain-Barre syndrome.  Cochrane Database Syst Rev. 2002;  CD001798
• 19 Toyka K V, Hartung H P. Chronic inflammatory polyneuritis and neuropathies.  Curr Opin Neurol. 1996;  9 240-250
• 20 Umapathi T, Hughes R A, Nobile-Orazio E, Leger J M. Immunosuppressive treatment for multifocal motor neuropathy.  Cochrane Database Syst Rev. 2002;  CD003217
• 21 Van der Meche F G, Schmitz P I. Dutch Guillain-Barre Study Group . A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome.  N Engl J Med. 1992;  326 1123-1129
• 22 Van Koningsveld R, Schmitz P I, Ang C W. et al . Infections and course of disease in mild forms of Guillain-Barre syndrome.  Neurology. 2002;  58 610-614
• 23 Winer J B. Treatment of Guillain-Barre syndrome.  Quat J Med. 2002;  95 717-721
• 24 Wollinsky K H, Hulser P J, Brinkmeier H. et al . CSF filtration is an effective treatment of Guillain-Barre syndrome: a randomized clinical trial.  Neurology. 2001;  57 774-780

1 Der Beitrag „Akute und chronisch entzündliche Neuropathien - Diagnostik“ ist im vorhergehenden Heft (Nr. 24) erschienen.